Wednesday, July 8, 2026

Patent intelligence · US

US 8263102

Drug delivery coating for use with a stent

granted A61KA61K47/10A61K47/22A61K47/44
Status granted
Linked drugs 3
Pipeline programs 6
Years to expiry 6
Applicant portfolio 37
Patent details — US 8263102
Jurisdiction
US
Status
granted
Grant date
Sep 11, 2012
Expiration
Sep 6, 2032
Claims
56
CPC classes
A61K, A61K47/10, A61K47/22, A61K47/44
View on Google Patents ↗

Quick answer

US 8263102 (Drug delivery coating for use with a stent) is held by ATRIUM MEDICAL CORPORATION. Status: granted. Granted Sep 11, 2012. Expires Sep 6, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.

Key facts

Grant date
Expiration
Claims
56
CPC classes
A61K, A61K47/10, A61K47/22, A61K47/44, A61P, A61P29/00

More from ATRIUM MEDICAL CORPORATION

Related pharmaceutical patents in our USPTO index.

  1. US 11793912

    Cross-linked fatty acid-based biomaterials

    ATRIUM MEDICAL CORPORATION · Expires Oct 19, 2043

    granted
  2. US 11166929

    Fatty-acid based particles

    ATRIUM MEDICAL CORPORATION · Expires Nov 4, 2041

    granted
  3. US 11097035

    Compositions and methods for altering the rate of hydrolysis of cured oil-based materials

    ATRIUM MEDICAL CORPORATION · Expires Aug 19, 2041

    granted
  4. US 11083823

    Tissue-separating fatty acid adhesion barrier

    ATRIUM MEDICAL CORPORATION · Expires Aug 5, 2041

    granted
  5. US 10888617

    Cured oil-hydrogel biomaterial compositions for controlled drug delivery

    ATRIUM MEDICAL CORPORATION · Expires Jan 7, 2041

    granted
  6. US 10869902

    Cured gel and method of making

    ATRIUM MEDICAL CORPORATION · Expires Dec 17, 2040

    granted
  7. US 10864304

    Anti-infective antimicrobial-containing biomaterials

    ATRIUM MEDICAL CORPORATION · Expires Dec 10, 2040

    granted
  8. US 10814043

    Cross-linked fatty acid-based biomaterials

    ATRIUM MEDICAL CORPORATION · Expires Oct 22, 2040

    granted

Frequently asked questions

What is US patent 8263102?

US 8263102 (Drug delivery coating for use with a stent) is held by ATRIUM MEDICAL CORPORATION. Status: granted. Granted Sep 11, 2012. Expires Sep 6, 2032 (6 years remaining) — relevant for patent-cliff and LOE planning.

Who owns US 8263102?

ATRIUM MEDICAL CORPORATION is listed as the applicant in USPTO PatentsView records indexed by NovaPharmaNews. We track 37 pharmaceutical patents for this assignee.

When does US 8263102 expire?

Our index shows an expiration date of Sep 6, 2032 (6 years from today). Confirm material dates against USPTO, FDA Orange Book, or qualified counsel before contractual decisions.